CXCL8 and COVID-19: This information is in line with the fact that COVID-19 is characterized by the release of potent vascular permeability mediators such as arachidonic acid metabolites, IL-8, and monocyte chemoattractant protein-1 (MCP-1), all of which might contribute to the transvascular leakage of albumin [30].